Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Syndecan binding protein 2 pseudogene 1 (SDCBP2P1) is a genomic DNA sequence classified as a pseudogene—a non-coding counterpart of the functional gene SDCBP2 (syndecan binding protein 2)[5]. It does not produce an active protein. The functional gene SDCBP2 encodes a protein containing PDZ domains involved in nuclear PIP2 organization, cell division, and cell survival[7], but SDCBP2P1 only resembles its sequence and is not actively translated or part of a receptor, enzyme, transporter, or known therapeutic target pathway. Its presence is primarily relevant in the context of genomic studies, annotation, and evolutionary biology, not in drug discovery or disease targeting[5]. In summary: SDCBP2P1 is not considered a molecular target. It is a pseudogene and does not encode a receptor, enzyme, or other druggable entity[5][7]. There are no known biological functions or disease involvements attributed to this sequence[5].
None; as a pseudogene, it does not encode a protein that interacts with drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on syndecan binding protein 2 pseudogene 1 (SDCBP2P1).